{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T06:53:52Z","timestamp":1778914432336,"version":"3.51.4"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,6,30]],"date-time":"2015-06-30T00:00:00Z","timestamp":1435622400000},"content-version":"vor","delay-in-days":910,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.bbmt.2012.08.019","type":"journal-article","created":{"date-parts":[[2012,9,6]],"date-time":"2012-09-06T12:02:22Z","timestamp":1346932942000},"page":"143-149","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Single Cord Blood Combined with HLA-Mismatched Third Party Donor Cells: Comparable Results to Matched Unrelated Donor Transplantation in High-Risk Patients with Hematologic Disorders"],"prefix":"10.1016","volume":"19","author":[{"given":"Mi","family":"Kwon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascual","family":"Balsalobre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"P\u00e9rez Corral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ismael","family":"Bu\u00f1o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Anguita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Gayoso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Luis","family":"Diez-Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2012.08.019_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.bmt.1705866","article-title":"Eleven million donors in Bone Marrow Donors Worldwide! Time for reassessment?","volume":"41","author":"Van Rood","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2012.08.019_bib2","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1182\/blood.V98.8.2332","article-title":"Standardized, unrelated donor cord blood transplantation in adults with hematologic malignancies","volume":"98","author":"Sanz","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2012.08.019_bib3","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1038\/bmt.2012.13","article-title":"Single-unit umbilical cord blood transplantation from unrelated donors in patients with hematological malignancy using busulfan, thiotepa, fludarabine and ATG as myeloablative conditioning regimen","volume":"47","author":"Sanz","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2012.08.019_bib4","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1056\/NEJMoa041469","article-title":"Transplants of umbilical cord blood or bone marrow from unrelated donors in adults with acute leukemia","volume":"351","author":"Rocha","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bbmt.2012.08.019_bib5","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S1470-2045(10)70127-3","article-title":"Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis","volume":"11","author":"Eapen","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bbmt.2012.08.019_bib6","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.bbmt.2009.01.011","article-title":"Costs of hematopoietic cell transplantation: comparison of umbilical cord blood and matched related donor transplantation and the impact of posttransplant complications","volume":"15","author":"Majhail","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2012.08.019_bib7","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/bmt.2009.284","article-title":"Ex\u00a0vivo expansion of cord blood","volume":"44","author":"Kelly","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2012.08.019_bib8","doi-asserted-by":"crossref","first-page":"6083","DOI":"10.1182\/blood-2011-01-283606","article-title":"Ex\u00a0vivo expansion of human hematopoietic stem and progenitor cells","volume":"117","author":"Dahlberg","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2012.08.019_bib9","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1182\/blood-2009-05-220525","article-title":"Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 units","volume":"114","author":"Verneris","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2012.08.019_bib10","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S1470-2045(08)70180-3","article-title":"Direct intrabone transplant of unrelated cord-blood cells in acute leukaemia: a phase I\/II study","volume":"9","author":"Frassoni","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bbmt.2012.08.019_bib11","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0301-472X(03)00067-5","article-title":"Unrelated umbilical cord blood transplants in adults: early recovery of neutrophils by supportive co-transplantation of a low number of highly purified peripheral blood CD34+ cells from an HLA-haploidentical donor","volume":"31","author":"Fern\u00e1ndez","year":"2003","journal-title":"Exp Hematol"},{"key":"10.1016\/j.bbmt.2012.08.019_bib12","first-page":"640","article-title":"Early hematopoietic recovery after single unit unrelated cord blood transplantation in adults supported by co-infusion of mobilized stem cells from a third party donor","volume":"91","author":"Magro","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2012.08.019_bib13","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/bmt.2008.329","article-title":"Cord blood transplants supported by co-infusion of mobilized hematopoietic stem cells from a third-party donor","volume":"43","author":"Bautista","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2012.08.019_bib14","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1365-2141.2009.07766.x","article-title":"Improving the outcome of cord blood transplantation: use of mobilized HSC and other cells from third party donors","volume":"147","author":"Fern\u00e1ndez","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2012.08.019_bib15","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.beha.2010.05.002","volume":"23","author":"Sebrango","year":"2010","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.bbmt.2012.08.019_bib16","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1200\/JCO.2003.04.036","article-title":"Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia","volume":"21","author":"Cheson","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.bbmt.2012.08.019_bib17","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","article-title":"Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT","volume":"106","author":"Sorror","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2012.08.019_bib18","first-page":"1373","article-title":"A\u00a0comparison of fluorescent in situ hybridization and multiplex short tandem repeat polymerase chain reaction for quantifying chimerism after stem cell transplantation","volume":"90","author":"Bu\u00f1o","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2012.08.019_bib19","first-page":"825","article-title":"1994 Consensus Conference on Acute GVHD Grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2012.08.019_bib20","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease, I: Diagnosis and Staging Working Group report","volume":"11","author":"Filipovich","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2012.08.019_bib21","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O","article-title":"Estimation of failure probabilities in the presence of competing risks: new representations of old estimators","volume":"18","author":"Gooley","year":"1999","journal-title":"Stat Med"},{"key":"10.1016\/j.bbmt.2012.08.019_bib22","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/sj.bmt.1703260","article-title":"Statistical methods for the analysis and presentation of the results of bone marrow transplants, I: unadjusted analysis","volume":"28","author":"Klein","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2012.08.019_bib23","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1182\/blood.V118.21.654.654","article-title":"Co-infusion of allogeneic cord blood with haploidentical CD34+ cells improved transplant outcome for patients with severe aplastic anemia undergoing cord blood transplantation (ASH Annual Meeting Abstracts)","volume":"118","author":"Gormley","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2012.08.019_bib24","doi-asserted-by":"crossref","first-page":"6438","DOI":"10.1182\/blood-2011-08-372508","article-title":"Reduced-intensity conditioning with combined haploidentical and cord blood transplantation results in rapid engraftment, low GVHD, and durable remissions","volume":"118","author":"Liu","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2012.08.019_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V118.21.1.1","volume":"118","author":"Anasetti","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2012.08.019_bib26","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2796.2012.02547.x","article-title":"Bone marrow or peripheral blood stem cell transplantation from unrelated donors in adult patients with acute myeloid leukemia: an Acute Leukaemia Working Party analysis in 2262 patients","author":"Ringd\u00e9n","year":"2012","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.bbmt.2012.08.019_bib27","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/bmt.2008.40","article-title":"Early identification and management of graft failure after unrelated cord blood transplantation","volume":"42","author":"Chan","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2012.08.019_bib28","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1182\/blood-2009-07-231068","article-title":"Combined effect of total nucleated cell dose and HLA match on transplantation outcome in 1061 cord blood recipients with hematologic malignancies","volume":"115","author":"Barker","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2012.08.019_bib29","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1182\/blood-2002-01-0294","article-title":"Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival","volume":"100","author":"Wagner","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2012.08.019_bib30","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1200\/JCO.2007.15.8865","article-title":"Analysis of risk factors for outcomes after unrelated cord blood transplantation in adults with lymphoid malignancies: a study by the Eurocord-Netcord and Lymphoma Working Party of the European Group for Blood and Marrow Transplantation","volume":"27","author":"Rodrigues","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.bbmt.2012.08.019_bib31","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1182\/blood-2009-10-249219","article-title":"The impact of anti-HLA antibodies on unrelated cord blood transplantations","volume":"116","author":"Takanashi","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2012.08.019_bib32","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.bbmt.2011.01.011","article-title":"Total colony-forming units are a strong, independent predictor of neutrophil and platelet engraftment after unrelated umbilical cord blood transplantation: a single-center analysis of 435 cord blood transplants","volume":"17","author":"Page","year":"2011","journal-title":"Biol Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2012.08.019_bib33","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1182\/blood-2010-04-280966","article-title":"How I treat: the selection and acquisition of unrelated cord blood grafts","volume":"117","author":"Barker","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2012.08.019_bib34","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1053\/bbmt.2003.50026","article-title":"Chronic graft-versus-host disease","volume":"9","author":"Lee","year":"2003","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2012.08.019_bib35","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.1182\/blood-2010-11-319509","article-title":"Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD Consortium","volume":"117","author":"Pidala","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2012.08.019_bib36","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/bmt.2009.15","article-title":"Immune reconstitution after cord blood transplants supported by coinfusion of mobilized hematopoietic stem cells from a third-party donor","volume":"44","author":"Mart\u00edn-Donaire","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2012.08.019_bib37","first-page":"175","article-title":"Natural killer cell alloreactivity for leukemia therapy","volume":"28","author":"Ruggeri","year":"2005","journal-title":"J\u00a0Immunother"},{"key":"10.1016\/j.bbmt.2012.08.019_bib38","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1182\/blood-2011-03-344853","article-title":"Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts","volume":"118","author":"Brunstein","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2012.08.019_bib39","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1182\/blood-2011-11-354563","article-title":"Selection of optimal alternative graft source: mismatched unrelated donor, umbilical cord blood, or haploidentical transplant","volume":"119","author":"Ballen","year":"2012","journal-title":"Blood"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879112003539?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879112003539?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:44:28Z","timestamp":1761057868000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879112003539"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S1083879112003539"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2012.08.019","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Single Cord Blood Combined with HLA-Mismatched Third Party Donor Cells: Comparable Results to Matched Unrelated Donor Transplantation in High-Risk Patients with Hematologic Disorders","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2012.08.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}